Rising Certificate of Deposit Rates Signal Higher Retail Deposit Returns in India Standard Chartered Targets Higher Returns With Over 15 Reduction in Corporate Functions Roles by 2030 SP 500 Edges Higher as Healthcare and Tech Lead Communication Services Lag ATT CEO BlueCollar Workers Are Key to AI Economy But Supply Falls Short Volvo Cars Secures US Approval to Continue Importing Connected Vehicle Technology Bond Bull Market Poised for Further Gains as RBI Liquidity Measures Support Yields Experts Suggest RDW Q1 2026 Earnings EPS Misses Estimates Sharply Yet Stock Surges on Strategic Developments AAR Corp AIR Q1 2026 Earnings Strong EPS Beat Driven by Aftermarket Demand and Operational Discipline Weyco Group Q1 2026 Earnings Steady EPS Performance Amid Challenging Retail Environment NNOX Q4 2025 Earnings Significant EPS Miss as PreRevenue Stage Continues CRGY Q1 2026 Earnings Earnings Surge Past Estimates as Operational Efficiency Drives Strong Results GLDG Q1 2026 Earnings NarrowerThanExpected Loss Reflects Cost Discipline in PreRevenue Stage Vericel Corporation VCEL Edges Lower as Biotech Sector Faces Headwinds Fidus Investment Corporation FDUS Edges Lower as Price Tests Key Support Near 1770 Ligand Pharmaceuticals LGND Gains Momentum Approaching Key Resistance at 2408 Crexendo Inc CXDO Holds Steady Near Resistance Technical Levels in Focus Silicon Valley Acquisition Corp Warrants SVAQW Remain Flat at 031 as Trading Range Tightens British Flower Farms Gain Market Share Amid Shift Toward Hyperlocal EcoFriendly Produce US Stock Futures Bond Yields Decline as Putin Revises Nuclear Doctrine Global Equities Hit Record Highs on AI Optimism but Dalal Street Struggles Under Geopolitical and Oil Pressure Trump Delays AI Executive Order Signing Cites Concerns Over Potential Restrictions Regulatory Storm Brews 16 States Take Legal Action Against Prediction Markets Elon Musks Legal Setback Against OpenAI Why the Litigation Strategy May Continue CTMX Q1 2026 Earnings SmallerThanExpected Loss as Pipeline Progress Continues Bolt Biotherapeutics BOLT Edges Higher Amid Tight Trading Range Support and Resistance Levels in Focus